Influence of Moderate Inspired Oxygen Fraction (FiO2) and Protective Ventilation on Postoperative Pulmonary Complication
1 other identifier
interventional
280
1 country
1
Brief Summary
The purpose of this study is to determine the influence of moderate FiO2 and the lung protective ventilation on postoperative pulmonary complications following hepatic resection surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4
Started Mar 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2014
CompletedFirst Submitted
Initial submission to the registry
July 13, 2014
CompletedFirst Posted
Study publicly available on registry
July 23, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2015
CompletedJuly 23, 2014
July 1, 2014
1.3 years
July 13, 2014
July 22, 2014
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
a composite of pulmonary and extrapulmonary complications occurring by day 7 after surgery.
The primary outcome was a composite of major pulmonary complications (defined as pneumonia or need for invasive or noninvasive ventilation for acute respiratory failure) and extrapulmonary complications (defined as sepsis, septic shock, or death) within the first 7 days after surgery.
during the first seven days after surgery
Secondary Outcomes (2)
incidence of pulmonary complications
within the 30-day follow-up period
Oxidative stress markers
2 days
Study Arms (4)
FiO2 80%,Nonprotective Lung Ventilation
NO INTERVENTIONFiO2 30%,Nonprotective Lung Ventilation
EXPERIMENTALFiO2 30%,Nonprotective Lung Ventilation
FiO2 80%,protective Lung Ventilation
EXPERIMENTALFiO2 80% and protective Lung Ventilation
FiO2 30%,protective Lung Ventilation
EXPERIMENTALFiO2 30% and protective Lung Ventilation
Interventions
Eligibility Criteria
You may qualify if:
- ASA 1\~2,Planned intrabdominal hepatic resection surgery;
- Expected duration 2 hours to 6 hours;
- Age 40 yr to 70 yr);
- BMI 18-26.9kg/m2
- Risk of postoperative pulmonary complications (Arozullah score ≥2);
You may not qualify if:
- Noninvasive ventilation in the last 30 days;
- Recent history of pneumonia, ALI/ARDS (in the last 30 days);
- History of pulmonary resection;
- History of neuromuscular disease;
- Child-Pugh\>A grade;
- Patient refusal;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fenmei Shilead
Study Sites (1)
First Affiliated Hospital, Sun Yat-Sen University
Guangzhou, Guangdong, China
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- resident
Study Record Dates
First Submitted
July 13, 2014
First Posted
July 23, 2014
Study Start
March 1, 2014
Primary Completion
June 1, 2015
Study Completion
June 1, 2015
Last Updated
July 23, 2014
Record last verified: 2014-07